Plain-English translation of NCT07248371 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are trying to understand the early warning signs of serious diseases that develop from metabolic syndrome—a condition where your body has trouble managing blood sugar, blood pressure, and cholesterol. By analyzing your blood, urine, and stool samples using advanced genetic and molecular testing, they hope to create better ways to predict who will develop heart disease, kidney disease, or fatty liver disease, and catch these problems earlier.
Many people with metabolic syndrome don't know they're at risk for serious complications until it's too late. This study aims to find hidden biological signals in your body that could warn doctors about these dangers years before symptoms appear, so treatment can start sooner.
You likely qualify if…
You likely don't qualify if…
You would visit the hospital once a year for about 1–2 hours to provide small samples: a blood draw (about 2 teaspoons), a urine sample, and a stool sample. The researchers will track your health using your medical records over time. There are no medications or lifestyle changes required—you simply provide the samples and let them monitor your health through routine clinic visits and lab work.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Taiwan
Enrollment target
~6,266 participants
Started
June 2025
Primary completion
September 2028
Age range
20 Years and older
Last updated on clinicaltrials.gov in November 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Chi-Hsiao Yeh, MD PhD
Chang Gung Memorial Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.